Alpha DNA Investment Management’s iShares Core S&P Small-Cap ETF IJR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-724
Closed -$78K 351
2021
Q1
$78K Buy
724
+263
+57% +$27.5K 0.09% 135
2020
Q4
$42K Buy
+461
New +$37.9K 0.04% 194

Other funds holding IJR

Alpha DNA Investment Management's IJR Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of iShares Core S&P Small-Cap ETF (IJR) in Q2 2021, closing a stake of 724 shares — an estimated $78K sold.

Alpha DNA Investment Management first reported a position in IJR in Q4 2020 and held it in 2 quarters. The position peaked at $78K in Q1 2021. 1,813 funds tracked by Wall St. Rank hold IJR as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining iShares Core S&P Small-Cap ETF position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 724 iShares Core S&P Small-Cap ETF shares in Q2 2021, an estimated $78K.
  • Alpha DNA Investment Management first reported a position in iShares Core S&P Small-Cap ETF in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's iShares Core S&P Small-Cap ETF position peaked at $78K in Q1 2021.
  • 1,813 funds tracked by Wall St. Rank held iShares Core S&P Small-Cap ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.